TAPSE/sPAP ratio is a marker of cardiorenal syndrome type 2 in the systemic sclerosis EUSTAR cohort.

Amalia Colalillo,Chiara Pellicano,Lidia P Ananyeva,Eric Hachulla,Giovanna Cuomo, Andrea-Hermina Györfi,László Czirják,Jeska de Vries-Bouwstra,Luc Mouthon,Hadi Poormoghim,Francesco Del Galdo,Nicolas Hunzelmann,Julia Spierings,Masataka Kuwana,Edoardo Rosato

Arthritis care & research（2023）

引用 0|浏览21

暂无评分

摘要

Reduced TAPSE/sPAP ratio is independently associated with CKD. TAPSE/sPAP ratio ≤ 0.32 mm/mmHg and eGFR < 60 mL/min/1.73m are prognostic factors for all-cause mortality. In SSc patients with PH, eGFR is independent by reduced cardiac output. This article is protected by copyright. All rights reserved.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要